SCHEMBL10018191

SCHEMBL10018191

CC1(C)c2ccccc2-c2c(cc(O)c3cc(N4CCOCC4)ccc23)C1(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.47
PRKDC P78527 3/20 0.41
PIK3CA P42336 5/20 0.41
PIK3CD O00329 3/20 0.41
PIK3CB P42338 3/20 0.41
PIK3CG P48736 3/20 0.41
TDO2 P48775 1/20 0.40
IDO2 Q6ZQW0 1/20 0.40
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39
MAPT P10636 3/20 0.38
PKM P14618 1/20 0.38
PSMD14 O00487 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10049683 0.84 PDK2 (0.43) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL24605103 0.83 PDK2 (0.43) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL1711032 0.81 PDK2 (0.47) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL15449609 0.78 PDK2 (0.40) PDK2PRKDCPIK3CAHSD17B1HSD17B2
SCHEMBL1710808 0.76 ALK (0.42) PDK2PRKDCPIK3CAMAPTKMT2A
SCHEMBL10262943 0.76 PDK2 (0.39) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL13868673 0.76 HSD17B1 (0.40) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL15452246 0.75 PDK2 (0.38) PDK2PRKDCPIK3CAPIK3CDPIK3CB
SCHEMBL10262978 0.74 PDK2 (0.37) PDK2PIK3CAHSD17B1HSD17B2MAPT
SCHEMBL10267942 0.74 PDK2 (0.37) PDK2HSD17B1HSD17B2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8123987-B2 Chromene compounds TOKUYAMA CORPORATION (JP) 2012-02-28 US disclosed
US-20100230648-A1 Chromene Compounds TOKUYAMA CORPORATION (JP) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100230648-A1 Chromene Compounds H1-4, RB1, H1-0 PDK2 1595/4885PRKDC 3262/4885PIK3CA 663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.